Trustmark Corporation TRMK
46.04
(0.05)
(0.11%)
as of 25 Sep
- Market cap
- $2.7B
- P/E
- 11.7×
Follow TRMK
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
11.65 | 11.15 | 10.50 | 10.82 |
+8 more quarters Free account |
P/S ratio |
2.41 | 2.22 | 2.11 | 2.15 | |
P/FCF ratio |
14.94 | 15.09 | 10.31 | 8.84 | |
P/Operating CF |
47.38 | 91.48 | 40.76 | 36.05 | |
P/B ratio |
1.26 | 1.16 | 1.11 | 1.13 | |
Price to Tangible BV |
1.61 | 1.50 | 1.42 | 1.45 | |
EV/Sales |
2.02 | 1.96 | 1.72 | 1.65 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
10.85 | 11.59 | 7.85 | 6.45 | |
EV/FCF |
12.52 | 13.31 | 8.40 | 6.81 | |
Quick Ratio |
0.04 | 0.03 | 0.04 | 0.05 | |
Current Ratio |
0.89 | 0.89 | 0.89 | 0.88 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
1.22% | 1.23% | 1.24% | 0.99% | |
Debt/Equity |
0.11 | 0.11 | 0.11 | 0.09 | |
Asset Turnover |
0.06 | 0.06 | 0.06 | 0.06 | |
Operating CF/Net income |
0.89 | 0.48 | 1.00 | 1.17 | |
Capex/Depreciation |
(2.28) | (3.17) | (0.90) | (1.42) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.58% | 49.16% | 47.54% | 46.92% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.59% | 1.06% | 0.45% | 0.46% | |
Graham Net Nets |
(0.86) | (0.94) | (1.00) | (0.98) | |
Graham Number |
57.08 | 55.48 | 54.19 | 53.73 | |
Earnings Yield |
8.59% | 8.97% | 9.53% | 9.24% | |
Free Cash Flow Yield |
6.69% | 6.63% | 9.70% | 11.32% | |
Revenue per Share |
4.79 | 4.66 | 4.65 | 4.69 | |
Operating CF per Share |
0.97 | 0.46 | 0.96 | 1.10 | |
Capex per Share |
(0.15) | (0.16) | (0.08) | (0.08) | |
Free Cash Flow per Share |
0.82 | 0.30 | 0.88 | 1.02 | |
Cash per Share |
11.46 | 8.95 | 11.08 | 12.15 | |
Shareholders Equity per Share |
36.66 | 36.19 | 35.18 | 35.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
36.66 | 36.19 | 35.18 | 35.06 | |
Free Cash Flow |
48.13 | 17.82 | 52.78 | 61.28 | |
Working Capital |
(1,833.82) | (1,854.79) | (1,845.59) | (1,915.46) | |
Capital Expenditures |
(8.65) | (9.28) | (4.85) | (4.96) | |
Net Current Asset Value |
(2,313.59) | (2,322.93) | (2,339.57) | (2,343.36) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
22.69% | 20.45% | 20.63% | 20.09% | |
Price to Operating Income |
9.40 | 8.94 | 8.55 | 8.88 | |
| Other line items | |||||
Average Payables |
15,593.54 | 15,396.61 | 15,303.98 | 15,435.95 | |
Average Assets |
18,904.07 | 18,641.76 | 18,538.82 | 18,640.94 | |
Average Common Equity |
2,107.21 | 2,075.19 | 2,042.00 | 2,047.18 |
Columns are period end dates